Medical News

Coronary Flow Velocity Reserve Predicts Adverse Prognosis in...
Eur Heart J.

Assessment of CFVR by echocardiography is feasible and predictive of adverse outcome in women with angina and no...

03 Dec 2020

Prevalence, Features, and Prognosis of Artery‐to‐Artery Embo...
J Am Heart Assoc.

AAEMI is a rare cause for ST‐segment–elevation myocardial infarction and has unique morphological features of...

02 Dec 2020

Cardiac Procedural Myocardial Injury, Infarction, and Mortal...
Eur Heart J.

Our analysis has demonstrated that in CCS patients with normal baseline cTn levels, the post-PCI cTn elevation of ≥...

01 Dec 2020

Blood Pressure Variability and Outcome in Acute Severe Strok...
J Clin Hypertens.

In conclusion, the increased BPV was strongly correlated with poor outcomes in the subacute phase of severe stroke...

30 Nov 2020

Key Trials

Impact of Sacubitril/Valsartan on Sudden Cardiac Death as per ICD Use and HF Cause

This sub-group analysis of the PARADIGM HF study demonstrates under-usage of ICD in patients with HFrEF despite reduction in sudden cardiac death....

PIONEER HF: Sacubitril/valsartan in African-American Patients with ADHF

This subgroup analysis of the PIONEER-HF trial demonstrated sacubitril/valsartan to be equally effective and safe in African-American and non-...

Meta-analysis on the Efficacy and Safety of Sacubitril/valsartan in Heart Failure

According to this meta-analysis, sacubitril/valsartan, as compared with ACE inhibitors or ARBs, was associated with reduced risk of all-cause and CV...

Coadministration of Telmisartan/amlodipine and Rosuvastatin Safe and Effective in Hypertensive Patients with Dyslipidemia

Combined administration of telmisartan/amlodipine 80/5 mg and rosuvastatin 20 mg significantly reduced blood pressure and improved lipid control in...

Slide Library

Medical Management Strategy of CTEPH: Role of Riociguat

Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...

Email this page
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

Email this page

Our Publications

Telyse (Tenecteplase) Monograph

In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....

Mexiletine FAQ Booklet

Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...

Mexohar (Mexiletine) Monograph

About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...

Gutron (Midodrine hydrochloride) Monograph

Orthostatic Hypotension is common in elderly (>70 years of age) and can also occur secondary to neuropathy like in diabetes or central lesions...

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 


Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 


What percent of your patients who need oral anticoagulation, receive warfarin?
26% (6 votes)
22% (5 votes)
13% (3 votes)
13% (3 votes)
22% (5 votes)
Almost all
4% (1 vote)
Total votes: 23